Initiation of treatment with subcutaneous administration opens the door to fully at-home dosing, similar to injectable ...

How Ono International School's English-language master's program in visual art therapy is preparing a new generation of ...

A combination of THC and CBD eased symptoms in an especially frail population: patients with advanced dementia near the end ...

Avere Therapeutics has burst onto the scene by securing a public listing via a reverse merger with NextCure, while stocking ...

Arbutus (ABUS) looks stronger after Moderna validates its LNP patents, with imdusiran showing durable viral control and a ...

Agenus has scrapped a phase 3 study of its combo therapy in colorectal cancer after just three months in order to go all-in ...

Akeso, Inc. (9926.HK) (Akeso or the Company) today announced that it has entered into a collaboration with Memorial Sloan ...

Researchers at The University of Texas MD Anderson Cancer Center have discovered that an investigational epigenetic therapy ...

At RDE of 32 mg QD, encouraging monotherapy responses with 57% uORR in 2L+ KRAS G12X pancreatic cancer in U.S. trial and median relative dose intensity of 100% ...

CGON climbs as cretostimogene nears a planned 2026 BLA filing, posts encouraging phase II data. It maintains a cash position ...

Ian Wells, former Global Chief Financial Officer of HOYA Vision Care, appointed CFO, bringing multi-billion-dollar P&L leadership and capital-markets disciplineTom West, who led Intersect ENT to its ...

Cancer immunotherapy has revolutionized oncology, with immune checkpoint inhibitors (ICIs) becoming integral components of modern anti-cancer treatment ...